1. N. Gerber and K. Arnold. Studies on the metabolism of diphenylhydantoin in mice.J. Pharmacol. Exptl. Therap. 167: 77–90 (1969).
2. N. Gerber, W. L. Weller, R. Lynn, R. E. Rangno, B. J. Sweetman, and M. T. Bush. Study of dose-dependent metabolism of 5,5-diphenylhydantoin in the rat using new methodology for isolation and quantitation of metabolitesin vivo andin vitro.J. Pharmacol. Exptl. Therap. 178: 567–579 (1971).
3. P. G. Dayton, S. A. Cucinell, M. Weiss, and J. M. Perel. Dose dependence of drug plasma level decline in dogs.J. Pharmacol. Exptl. Therap. 158: 305–316 (1967).
4. K. Arnold and N. Gerber. The rate of decline of diphenylhydantoin in human plasma.Clin. Pharmacol. Therap. 11: 121–134 (1970).
5. N. Gerber and J. G. Wagner. Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.Res. Comm. Chem. Pathol. Pharmacol. 3: 455–466 (1972).